...
codx-img

Co-Diagnostics Inc, Common Stock

CODX

NAQ

$0.756

+$0.03

(4.11%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$23.28M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
64.09K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.85
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.7 L
$2.23 H
$0.756

About Co-Diagnostics Inc, Common Stock

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameCODXSectorS&P500
1-Week Return-7.72%-0.4%-1.9%
1-Month Return-26.35%-4.57%-0.37%
3-Month Return-39.74%-10.14%4.19%
6-Month Return-47.55%-5.67%9.34%
1-Year Return-36.6%2.53%25.19%
3-Year Return-92.25%-0.39%26.48%
5-Year Return-24.45%34.57%85.39%
10-Year Return-87.45%103.62%187.16%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue214.97K74.55M97.89M34.22M6.81M[{"date":"2019-12-31","value":0.22,"profit":true},{"date":"2020-12-31","value":76.16,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":34.96,"profit":true},{"date":"2023-12-31","value":6.96,"profit":true}]
Cost of Revenue112.43K16.59M11.57M5.48M4.18M[{"date":"2019-12-31","value":0.68,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":69.76,"profit":true},{"date":"2022-12-31","value":33.04,"profit":true},{"date":"2023-12-31","value":25.22,"profit":true}]
Gross Profit102.54K57.96M86.31M28.74M2.63M[{"date":"2019-12-31","value":0.12,"profit":true},{"date":"2020-12-31","value":67.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.29,"profit":true},{"date":"2023-12-31","value":3.04,"profit":true}]
Gross Margin47.70%77.75%88.18%83.98%38.57%[{"date":"2019-12-31","value":54.1,"profit":true},{"date":"2020-12-31","value":88.17,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.24,"profit":true},{"date":"2023-12-31","value":43.74,"profit":true}]
Operating Expenses6.00M16.27M40.25M40.33M44.10M[{"date":"2019-12-31","value":13.6,"profit":true},{"date":"2020-12-31","value":36.89,"profit":true},{"date":"2021-12-31","value":91.25,"profit":true},{"date":"2022-12-31","value":91.44,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(5.89M)41.69M46.06M(11.59M)(42.71M)[{"date":"2019-12-31","value":-12.79,"profit":false},{"date":"2020-12-31","value":90.51,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-25.16,"profit":false},{"date":"2023-12-31","value":-92.71,"profit":false}]
Total Non-Operating Income/Expense(371.60K)972.64K(383.53K)8.84M5.65M[{"date":"2019-12-31","value":-4.21,"profit":false},{"date":"2020-12-31","value":11.01,"profit":true},{"date":"2021-12-31","value":-4.34,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.89,"profit":true}]
Pre-Tax Income(6.20M)42.57M45.64M(18.85M)(38.11M)[{"date":"2019-12-31","value":-13.58,"profit":false},{"date":"2020-12-31","value":93.28,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-41.3,"profit":false},{"date":"2023-12-31","value":-83.51,"profit":false}]
Income Taxes(126.44K)90.54K8.98M(4.61M)(2.78M)[{"date":"2019-12-31","value":-1.41,"profit":false},{"date":"2020-12-31","value":1.01,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-51.34,"profit":false},{"date":"2023-12-31","value":-30.94,"profit":false}]
Income After Taxes(6.07M)42.48M36.66M(14.24M)(35.33M)[{"date":"2019-12-31","value":-14.29,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":86.3,"profit":true},{"date":"2022-12-31","value":-33.52,"profit":false},{"date":"2023-12-31","value":-83.18,"profit":false}]
Income From Continuous Operations(6.20M)42.48M36.66M(14.24M)(42.56M)[{"date":"2019-12-31","value":-14.59,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":86.3,"profit":true},{"date":"2022-12-31","value":-33.52,"profit":false},{"date":"2023-12-31","value":-100.2,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(6.07M)42.48M36.66M(14.24M)(35.33M)[{"date":"2019-12-31","value":-14.29,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":86.3,"profit":true},{"date":"2022-12-31","value":-33.52,"profit":false},{"date":"2023-12-31","value":-83.18,"profit":false}]
EPS (Diluted)(0.36)1.361.22(0.46)(1.21)[{"date":"2019-12-31","value":-26.47,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":89.71,"profit":true},{"date":"2022-12-31","value":-33.82,"profit":false},{"date":"2023-12-31","value":-88.97,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CODX
Cash Ratio 6.50
Current Ratio 6.92
Quick Ratio 6.70

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CODX
ROA (LTM) -27.61%
ROE (LTM) -50.57%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CODX
Debt Ratio Lower is generally better. Negative is bad. 0.12
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.88

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CODX
Trailing PE NM
Forward PE 16.00
P/S (TTM) 3.18
P/B 0.36
Price/FCF NM
EV/R 0.06
EV/Ebitda 0.52
PEG NM

FAQs

What is Co-Diagnostics Inc share price today?

Co-Diagnostics Inc (CODX) share price today is $0.756

Can Indians buy Co-Diagnostics Inc shares?

Yes, Indians can buy shares of Co-Diagnostics Inc (CODX) on Vested. To buy Co-Diagnostics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CODX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Co-Diagnostics Inc be purchased?

Yes, you can purchase fractional shares of Co-Diagnostics Inc (CODX) via the Vested app. You can start investing in Co-Diagnostics Inc (CODX) with a minimum investment of $1.

How to invest in Co-Diagnostics Inc shares from India?

You can invest in shares of Co-Diagnostics Inc (CODX) via Vested in three simple steps:

  • Click on Sign Up or Invest in CODX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Co-Diagnostics Inc shares
What is Co-Diagnostics Inc 52-week high and low stock price?

The 52-week high price of Co-Diagnostics Inc (CODX) is $2.23. The 52-week low price of Co-Diagnostics Inc (CODX) is $0.7.

What is Co-Diagnostics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Co-Diagnostics Inc (CODX) is

What is Co-Diagnostics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Co-Diagnostics Inc (CODX) is 0.36

What is Co-Diagnostics Inc dividend yield?

The dividend yield of Co-Diagnostics Inc (CODX) is 0.00%

What is the Market Cap of Co-Diagnostics Inc?

The market capitalization of Co-Diagnostics Inc (CODX) is $23.28M

What is Co-Diagnostics Inc’s stock symbol?

The stock symbol (or ticker) of Co-Diagnostics Inc is CODX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top